Ethyl 3-bromo-4-(4-methylpiperazin-1-yl)benzoate

Catalog No. :
ACFMDU152
CAS No. :
1131594-69-8
Molecular Formula :
C14H19BrN2O2
Molecular Weight :
327.22

IUPAC Name:ethyl 3-bromo-4-(4-methylpiperazin-1-yl)benzoate

Ethyl 3-bromo-4-(4-methylpiperazin-1-yl)benzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$83.00Login to see priceIn stockInquiry
1g95%$207.00Login to see priceIn stockInquiry
5g95%$585.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 3-bromo-4-(4-methylpiperazin-1-yl)benzoate
IUPAC Nameethyl 3-bromo-4-(4-methylpiperazin-1-yl)benzoate
MDL No.MFCD11110937
Molecular FormulaC14H19BrN2O2
Molecular Weight327.22
SMILESO=C(OCC)C1=CC=C(N2CCN(C)CC2)C(Br)=C1
InChI KeyPHLZSBLTLYGWOM-UHFFFAOYSA-N
SynonymEthyl 3-broMo-4-(4-Methylpiperazin-1-yl)benzoate;PHLZSBLTLYGWOM-UHFFFAOYSA-N;Ethyl 3-Bromo-4-(4-methyl-1-piperazinyl)benzoate;Benzoic acid, 3-bromo-4-(4-methyl-1-piperazinyl)-, ethyl ester
CAS No.1131594-69-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACFMDU152 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFMDU152 route product structure diagram
    ACFMDU1521131594-69-8 In Stock
Inquiry

2. ACFMDU152 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJACD865 route compound structure diagram
    ACJACD86534352-59-5 In Stock
  4. Then
  5. ACFMDU152 route product structure diagram
    ACFMDU1521131594-69-8 In Stock
Inquiry

Comments (0)